ScholarIQanswers from OpenAlex

Low-dose hydrocortisone reduces norepinephrine duration in severe burn patients: a randomized clinical trial

PaperCitations, authors & open-access status

Low-dose hydrocortisone reduces norepinephrine duration in severe burn patients: a randomized clinical trial is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Low-dose hydrocortisone reduces norepinephrine duration in severe burn patients: a randomized clinical trial have?

ScholarIQcitation count

Low-dose hydrocortisone reduces norepinephrine duration in severe burn patients: a randomized clinical trial has 37 citations in the OpenAlex counts ScholarIQ stores.

When was Low-dose hydrocortisone reduces norepinephrine duration in severe burn patients: a randomized clinical trial published?

ScholarIQyear

Low-dose hydrocortisone reduces norepinephrine duration in severe burn patients: a randomized clinical trial has 2015 year in the ScholarIQ index.

What is the open-access status of Low-dose hydrocortisone reduces norepinephrine duration in severe burn patients: a randomized clinical trial?

ScholarIQoa status

Low-dose hydrocortisone reduces norepinephrine duration in severe burn patients: a randomized clinical trial has gold oa status in the ScholarIQ index.

What is the DOI of Low-dose hydrocortisone reduces norepinephrine duration in severe burn patients: a randomized clinical trial?

ScholarIQdoi

The DOI for Low-dose hydrocortisone reduces norepinephrine duration in severe burn patients: a randomized clinical trial is on the source record.

What is the PMID of Low-dose hydrocortisone reduces norepinephrine duration in severe burn patients: a randomized clinical trial?

ScholarIQpmid

The PMID for Low-dose hydrocortisone reduces norepinephrine duration in severe burn patients: a randomized clinical trial is on the source record.

What is the OpenAlex record for Low-dose hydrocortisone reduces norepinephrine duration in severe burn patients: a randomized clinical trial?

ScholarIQopenalex

The OpenAlex for Low-dose hydrocortisone reduces norepinephrine duration in severe burn patients: a randomized clinical trial is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial